Professional Documents
Culture Documents
Arbovírus PDF
Arbovírus PDF
LFAM@UFPA.BR
Pathways to neuronal injury and
apoptosis in HIV-associated dementia CONCEITO DE ARBOVÍRUS
Marcus Kaul*, Gwenn A. Garden† & Stuart A. Lipton*
*Center for Neuroscience and Aging Research, The Burnham Institute, 10901 North Torrey Pines Road, La Jol a, California 92037, USA
(e-mail: mkaul@burnham.org and slipton@burnham.org)
†Department of Neurology, University of Washington, Seattle, Washington 98195, USA (email: gagarden@u.washington.edu)
Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming occurrence worldwide. The
mechanism remains poorly understood, but discovery in brain of HIV-1-binding sites (chemokine receptors)
• Arthropod-borne = arbovírus
provides new insights. HIV-1 infects macrophages and microglia, but not neurons, although neurons are
injured and die by apoptosis. The predominant pathway to neuronal injury is indirect through release of
macrophage, microglial and astrocyte toxins, although direct injury by viral proteins might also contribute.
These toxins overstimulate neurons, resulting in the formation of free radicals and excitotoxicity, similar to
other neurodegenerative diseases. Recent advances in understanding the signalling pathways mediating
these events offer hope for therapeutic intervention.
T
independent risk factor for AIDS mortality9. These findings
transovariana)
eventually increase as people live longer with AIDS5,6. with a decrease in the incidence of HAD, whether this effect
Currently there is no specific treatment for HAD, mainly wil be long lasting is open to question4,12. In fact, distinct
because of an incomplete understanding of how HIV antiviral drug-resistance patterns in the plasma and
infection causes neuronal injury and apoptosis. The cerebrospinal fluid (CSF) compartments have recently been
principal pathway for HIV entry into the central nervous reported13. It is possible that the proportion of HIV-infected
system (CNS) is through infected monocytes. The individuals who develop disability secondary to HAD wil
predominant pathogenesis of HAD is believed to involve increase as improvements in control of peripheral viral
activation of monocytic cells (macrophages and replication and the treatment of opportunistic infections
microglia) and their subsequent release of toxins that lead continue to extend life expectancy, resulting in an increase in
to neuronal and astrocytic dysfunction. Macrophages and theoverallprevalenceofHAD.Amorecompleteunderstand-
microglia can be activated by HIV infection itself, by ing of the pathogenesis of HAD wil help identify therapeutic
T
Control of urban Control of
he syndrome of cognitive and motor independent vectors orfindings
risk factor for AIDS mortality . These 9 arboreal vectors
dysfunction observed after infection with supportmodula!on
the hypot h esis that HAART does not provide of or modula!on of
human HIV-1 has been designated HIV- complete protection from the development of HAD.
associated dementia (HAD). Although highly Unfurban
ortunately, HIV protease inhibitovectorial
rs and several of the their vectorial
active antiretroviral therapy (HAART) has nuclcapacity;
eoside analogues penetrate poorly into the CNS , allow- 11
capacity;
1,2
resulted in a decrease in the incidence of HAD , it does ingearlyCNSinfectiontoevolveindependentlyovertimeina
not seem to provide complete protection from or reversal protimmuniza!on
ected brain reservoir. Thus, despite the finding that of immuniza!on of
3,4
urban
of HAD , and the prevalence of the dementia may improved systemic control of viral replication is associated
5,6
eventually increase as people live longer with AIDS . with a decrease in the incidence of HAD, whether this effect
enzoo!c NHP
Currently there is no specific treatment for HAD, mainly wilpopula!ons
be long lasting is open to question . In fact, distinct 4,12
hosts
because of an incomplete understanding of how HIV antiviral drug-resistance patterns in the plasma and
infection causes neuronal injury and apoptosis. The cerebrospinal fluid (CSF) compartments have recently been
principal pathway for HIV entry into the central nervous reported13. It is possible that the proportion of HIV-infected
system (CNS) is through infected monocytes. The individuals who develop disability secondary to HAD wil Targeted
predominant pathogenesis of HAD is believed to involve increase as improvements in control of peripheral viral
activation of monocytic cells (macrophages and replication and the treatment of opportunistic infections
vaccina!on of
microglia) and their subsequent release of toxins that lead continue to extend life expectControl
ancy, resulting in an increase in of urban people exposed
to neuronal and astrocytic dysfunction. Macrophages and theoverallprevalenceofHAD.Amorecompleteunderstand-
microglia can be activated by HIV infection itself, by ing of the pathogenesis of HADvectors wil help identify therapeutic or
to enzoo!c
interaction with viral proteins, or by immune stimulation targets for its prevention andmodula!on
Aedes spp. spillover;
treatment. of
due to concurrent infection or other factors7. It is possible
that direct effects of viral proteins on neurons may also HIV entry into the brain andurban initiation of HAD vectorial reduc!on of
contribute to neurodegeneration, although neurons HIV enters the CNS early incapacity; the course of infection, and the exposure to
themselves are not infected by HIV-1. Here we review the virus resides primarily in microglia and macrophages. A. aegyp! enzoo!c vectors
extracellular and intracellular signalling pathways leading However, infection of these celimmuniza!on of
A. albopictus
ls may not be sufficient to ini-
to macrophage or microglial activation, as well as those tiate neurodegeneration . Iturban12
has been proposed that factors
induced in neurons and astrocytes. These pathways are of associated with advanced HIV infection in the periphery
potential therapeutic importance as targets for the (non-CNS) are important popula!ons triggers for events leading to
prevention or treatment of HAD. dementia. One such factor could be the increased number
TheprevalenceofHADwasestimatedintheearly1990sto of circulating monocytes that express CD16 and CD69.
be as high as 20–30% of those patients with advanced HIV These activated cells adhere to the normal endothelium of
disease and low CD4 counts8. Many experts believe that HAD the brain microvasculature, transmigrate, and then trigger
is now the most common cause of dementia worldwide a number of deleterious processes12.
among people aged 40 or less, and it is a significant indepen- The blood–brain barrier (BBB) is crucial in HIV infec- (2) Human urban amplifica!on (1) Spillover from enzoo!c cycle
dent risk factor for death due to AIDS9. With the advent of tion of the CNS12,14. Microglial and astrocytic chemokines
HAART, the incidence of HAD decreased to as low as 10.5% (cell migration (chemotaxis)-inducing cytokines), such as TRENDS in Microbiology
(ref. 10), but in recent years its incidence as an AIDS-defining monocyte chemoattractant protein (MCP)-1, seem to
il ness has actually increased3. The proportion of new cases of regulate migration of peripheral blood mononuclear cells
Figure
HAD demonstrating a CD42. count greaterCartoon
than 200 !l"1 is through the BBB14. Hisdepicting
tological studies in specimens from the emergence of urban transmission cycles for dengue virus (DENV), yellow fever virus (YFV), and chikungunya virus (CHIKV) from enzootic
10
al so increasi ng . Moreover , a less ful m inant form of HIV-1-in fe cte d humans and si m i an i m munodef ic i ency
cycles. Lines through arrows indicate potential points for intervention in enzootic circulation, spillover infections of humans, introductions into the urban cycle, and
neurological dysfunction, termed minor cognitive/motor virus (SIV)-infected rhesus macaques show that lympho-
spillback
disorder (MCMD), may be more prevalfrom ent than frank cytesurban
and monocytes migrate into thcycles e brain15,16. However, to initiate arboreal enzootic cycles. The line thickness reflects the likelihood of success of these interventions (a thicker line indicates a greater
dementia in the HAART era, and remains of
likelihood a significantsuccess).
the pathophysiological relevance of CNS-invading
988 NATURE | VOL 410 | 19 APRIL 2001 | www.nature.com
Propriedades
Arboviruses
T Gênero
he syndrome of cognitive and motor independent risk factor for AIDS mortality9. These findings
dysfunction observed after infection with support the hypothesis that HAART does not provide
Flavivirus Alphavirus
human HIV-1 has been designated HIV- complete protection from the development of HAD.
associated dementia (HAD). Although highly Unfortunately, HIV protease inhibitors and several of the
active antiretroviral therapy (HAART) has nucleoside analogues penetrate poorly into the CNS11, allow-
resulted in a decrease in the incidence of HAD1,2, it does ingearlyCNSinfectiontoevolveindependentlyovertimeina
not seem to provide complete protection from or reversal protected brain reservoir. Thus, despite the finding that
of HAD3,4, and the prevalence of the dementia may improved systemic control of viral replication is associated
eventually increase as people live longer with AIDS5,6. with a decrease in the incidence of HAD, whether this effect
Currently there is no specific treatment for HAD, mainly wil be long lasting is open to question4,12. In fact, distinct
because of an incomplete understanding of how HIV antiviral drug-resistance patterns in the plasma and
infection causes neuronal injury and apoptosis. The cerebrospinal fluid (CSF) compartments have recently been
principal pathway for HIV entry into the central nervous reported13. It is possible that the proportion of HIV-infected
system (CNS) is through infected monocytes. The individuals who develop disability secondary to HAD wil
predominant pathogenesis of HAD is believed to involve increase as improvements in control of peripheral viral
activation of monocytic cells (macrophages and replication and the treatment of opportunistic infections
microglia) and their subsequent release of toxins that lead continue to extend life expectancy, resulting in an increase in
Febre amarela
to neuronal and astrocytic dysfunction. Macrophages and theoverallprevalenceofHAD.Amorecompleteunderstand-
Mayaro
microglia can be activated by HIV infection itself, by ing of the pathogenesis of HAD wil help identify therapeutic
interaction with viral proteins, or by immune stimulation targets for its prevention and treatment.
Espécies
due to concurrent infection or other factors7. It is possible
Dengue
that direct effects of viral proteins on neurons may also HIV entry into the brain and initiation of HAD
Chikungunya
contribute to neurodegeneration, although neurons HIV enters the CNS early in the course of infection, and the
themselves are not infected by HIV-1. Here we review the virus resides primarily in microglia and macrophages.
extracellular and intracellular signalling pathways leading However, infection of these cells may not be sufficient to ini-
Zika
to macrophage or microglial activation, as well as those tiate neurodegeneration12. It has been proposed that factors
induced in neurons and astrocytes. These pathways are of associated with advanced HIV infection in the periphery
potential therapeutic importance as targets for the (non-CNS) are important triggers for events leading to
prevention or treatment of HAD. dementia. One such factor could be the increased number
TheprevalenceofHADwasestimatedintheearly1990sto of circulating monocytes that express CD16 and CD69.
be as high as 20–30% of those patients with advanced HIV These activated cells adhere to the normal endothelium of
disease and low CD4 counts8. Many experts believe that HAD the brain microvasculature, transmigrate, and then trigger
is now the most common cause of dementia worldwide a number of deleterious processes12.
among people aged 40 or less, and it is a significant indepen- The blood–brain barrier (BBB) is crucial in HIV infec-
dent risk factor for death due to AIDS9. With the advent of tion of the CNS12,14. Microglial and astrocytic chemokines
HAART, the incidence of HAD decreased to as low as 10.5% (cell migration (chemotaxis)-inducing cytokines), such as
(ref. 10), but in recent years its incidence as an AIDS-defining monocyte chemoattractant protein (MCP)-1, seem to
il ness has actually increased3. The proportion of new cases of regulate migration of peripheral blood mononuclear cells
HAD demonstrating a CD4 count greater than 200 !l"1 is through the BBB14. Histological studies in specimens from
also increasing10. Moreover, a less fulminant form of HIV-1-infected humans and simian immunodeficiency
neurological dysfunction, termed minor cognitive/motor virus (SIV)-infected rhesus macaques show that lympho-
disorder (MCMD), may be more prevalent than frank cytes and monocytes migrate into the brain15,16. However,
dementia in the HAART era, and remains a significant the pathophysiological relevance of CNS-invading
988 NATURE | VOL 410 | 19 APRIL 2001 | www.nature.com
Pathways to neuronal injury and Arbovírus no Brasil
apoptosis in HIV-associated dementia
Marcus Kaul*, Gwenn A. Garden† & Stuart A. Lipton*
*Center for Neuroscience and Aging Research, The Burnham Institute, 10901 North Torrey Pines Road, La Jol a, California 92037, USA
Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming occurrence worldwide. The
mechanism remains poorly understood, but discovery in brain of HIV-1-binding sites (chemokine receptors)
provides new insights. HIV-1 infects macrophages and microglia, but not neurons, although neurons are
injured and die by apoptosis. The predominant pathway to neuronal injury is indirect through release of
macrophage, microglial and astrocyte toxins, although direct injury by viral proteins might also contribute.
These toxins overstimulate neurons, resulting in the formation of free radicals and excitotoxicity, similar to
T
he syndrome of cognitive and motor independent risk factor for AIDS mortality9. These findings
dysfunction observed after infection with support the hypothesis that HAART does not provide
human HIV-1 has been designated HIV- complete protection from the development of HAD.
associated dementia (HAD). Although highly Unfortunately, HIV protease inhibitors and several of the
nucleoside analogues penetrate poorly into the CNS11, allow-
Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming occurrence worldwide. The
mechanism remains poorly understood, but discovery in brain of HIV-1-binding sites (chemokine receptors)
provides new insights. HIV-1 infects macrophages and microglia, but not neurons, although neurons are
injured and die by apoptosis. The predominant pathway to neuronal injury is indirect through release of
macrophage, microglial and astrocyte toxins, although direct injury by viral proteins might also contribute.
T
he syndrome of cognitive and motor independent risk factor for AIDS mortality9. These findings
T
he syndrome of cognitive and motor independent risk factor for AIDS mortality9. These findings
Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming occurrence worldwide. The
mechanism remains poorly understood, but discovery in brain of HIV-1-binding sites (chemokine receptors)
• Isolamento Viral
provides new insights. HIV-1 infects macrophages and microglia, but not neurons, although neurons are
injured and die by apoptosis. The predominant pathway to neuronal injury is indirect through release of
macrophage, microglial and astrocyte toxins, although direct injury by viral proteins might also contribute.
These toxins overstimulate neurons, resulting in the formation of free radicals and excitotoxicity, similar to
other neurodegenerative diseases. Recent advances in understanding the signalling pathways mediating
these events offer hope for therapeutic intervention.
T
• Deteção de antígenos
he syndrome of cognitive and motor independent risk factor for AIDS mortality9. These findings
dysfunction observed after infection with support the hypothesis that HAART does not provide
human HIV-1 has been designated HIV- complete protection from the development of HAD.
associated dementia (HAD). Although highly Unfortunately, HIV protease inhibitors and several of the
active antiretroviral therapy (HAART) has nucleoside analogues penetrate poorly into the CNS11, allow-
• Provas sorológicas
predominant pathogenesis of HAD is believed to involve increase as improvements in control of peripheral viral
activation of monocytic cells (macrophages and replication and the treatment of opportunistic infections
microglia) and their subsequent release of toxins that lead continue to extend life expectancy, resulting in an increase in
to neuronal and astrocytic dysfunction. Macrophages and theoverallprevalenceofHAD.Amorecompleteunderstand-
microglia can be activated by HIV infection itself, by ing of the pathogenesis of HAD wil help identify therapeutic
• IH, FC TN
interaction with viral proteins, or by immune stimulation targets for its prevention and treatment.
due to concurrent infection or other factors7. It is possible
that direct effects of viral proteins on neurons may also HIV entry into the brain and initiation of HAD
contribute to neurodegeneration, although neurons HIV enters the CNS early in the course of infection, and the
themselves are not infected by HIV-1. Here we review the virus resides primarily in microglia and macrophages.
• ELISA
extracellular and intracellular signalling pathways leading However, infection of these cells may not be sufficient to ini-
to macrophage or microglial activation, as well as those tiate neurodegeneration12. It has been proposed that factors
induced in neurons and astrocytes. These pathways are of associated with advanced HIV infection in the periphery
potential therapeutic importance as targets for the (non-CNS) are important triggers for events leading to
prevention or treatment of HAD. dementia. One such factor could be the increased number
TheprevalenceofHADwasestimatedintheearly1990sto of circulating monocytes that express CD16 and CD69.
be as high as 20–30% of those patients with advanced HIV These activated cells adhere to the normal endothelium of
disease and low CD4 counts8. Many experts believe that HAD the brain microvasculature, transmigrate, and then trigger
is now the most common cause of dementia worldwide a number of deleterious processes12.
among people aged 40 or less, and it is a significant indepen- The blood–brain barrier (BBB) is crucial in HIV infec-
dent risk factor for death due to AIDS9. With the advent of tion of the CNS12,14. Microglial and astrocytic chemokines
Família Flaviviridae
macrophage, microglial and astrocyte toxins, although direct injury by viral proteins might also contribute.
These toxins overstimulate neurons, resulting in the formation of free radicals and excitotoxicity, similar to
other neurodegenerative diseases. Recent advances in understanding the signalling pathways mediating
these events offer hope for therapeutic intervention.
TGênero Flavivirus
he syndrome of cognitive and motor independent risk factor for AIDS mortality9. These findings
dysfunction observed after infection with support the hypothesis that HAART does not provide
human HIV-1 has been designated HIV- complete protection from the development of HAD.
associated dementia (HAD). Although highly Unfortunately, HIV protease inhibitors and several of the
active antiretroviral therapy (HAART) has nucleoside analogues penetrate poorly into the CNS11, allow-
resulted in a decrease in the incidence of HAD1,2, it does ingearlyCNSinfectiontoevolveindependentlyovertimeina
not seem to provide complete protection from or reversal protected brain reservoir. Thus, despite the finding that
of HAD3,4, and the prevalence of the dementia may improved systemic control of viral replication is associated
eventually increase as people live longer with AIDS5,6. with a decrease in the incidence of HAD, whether this effect
Currently there is no specific treatment for HAD, mainly wil be long lasting is open to question4,12. In fact, distinct
RNAfs (+)
because of an incomplete understanding of how HIV
infection causes neuronal injury and apoptosis. The
principal pathway for HIV entry into the central nervous
system (CNS) is through infected monocytes. The
antiviral drug-resistance patterns in the plasma and
cerebrospinal fluid (CSF) compartments have recently been
reported13. It is possible that the proportion of HIV-infected
individuals who develop disability secondary to HAD wil
predominant pathogenesis of HAD is believed to involve increase as improvements in control of peripheral viral
activation of monocytic cells (macrophages and replication and the treatment of opportunistic infections
microglia) and their subsequent release of toxins that lead continue to extend life expectancy, resulting in an increase in
to neuronal and astrocytic dysfunction. Macrophages and theoverallprevalenceofHAD.Amorecompleteunderstand-
70 nm
microglia can be activated by HIV infection itself, by
interaction with viral proteins, or by immune stimulation
due to concurrent infection or other factors7. It is possible
that direct effects of viral proteins on neurons may also
ing of the pathogenesis of HAD wil help identify therapeutic
targets for its prevention and treatment.
humanos
also increasing10. Moreover, a less fulminant form of
neurological dysfunction, termed minor cognitive/motor
disorder (MCMD), may be more prevalent than frank
dementia in the HAART era, and remains a significant
HIV-1-infected humans and simian immunodeficiency
virus (SIV)-infected rhesus macaques show that lympho-
cytes and monocytes migrate into the brain15,16. However,
the pathophysiological relevance of CNS-invading
988 NATURE | VOL 410 | 19 APRIL 2001 | www.nature.com
Febre amarela
Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming occurrence worldwide. The
mechanism remains poorly understood, but discovery in brain of HIV-1-binding sites (chemokine receptors)
provides new insights. HIV-1 infects macrophages and microglia, but not neurons, although neurons are
injured and die by apoptosis. The predominant pathway to neuronal injury is indirect through release of
macrophage, microglial and astrocyte toxins, although direct injury by viral proteins might also contribute.
These toxins overstimulate neurons, resulting in the formation of free radicals and excitotoxicity, similar to
other neurodegenerative diseases. Recent advances in understanding the signalling pathways mediating
these events offer hope for therapeutic intervention.
T
he syndrome of cognitive and motor independent risk factor for AIDS mortality9. These findings
dysfunction observed after infection with support the hypothesis that HAART does not provide
human HIV-1 has been designated HIV- complete protection from the development of HAD.
associated dementia (HAD). Although highly Unfortunately, HIV protease inhibitors and several of the
active antiretroviral therapy (HAART) has nucleoside analogues penetrate poorly into the CNS11, allow-
resulted in a decrease in the incidence of HAD1,2, it does ingearlyCNSinfectiontoevolveindependentlyovertimeina
not seem to provide complete protection from or reversal protected brain reservoir. Thus, despite the finding that
of HAD3,4, and the prevalence of the dementia may improved systemic control of viral replication is associated
eventually increase as people live longer with AIDS5,6. with a decrease in the incidence of HAD, whether this effect
Currently there is no specific treatment for HAD, mainly wil be long lasting is open to question4,12. In fact, distinct
because of an incomplete understanding of how HIV antiviral drug-resistance patterns in the plasma and
infection causes neuronal injury and apoptosis. The cerebrospinal fluid (CSF) compartments have recently been
principal pathway for HIV entry into the central nervous reported13. It is possible that the proportion of HIV-infected
system (CNS) is through infected monocytes. The individuals who develop disability secondary to HAD wil
predominant pathogenesis of HAD is believed to involve increase as improvements in control of peripheral viral
activation of monocytic cells (macrophages and replication and the treatment of opportunistic infections
microglia) and their subsequent release of toxins that lead continue to extend life expectancy, resulting in an increase in
to neuronal and astrocytic dysfunction. Macrophages and theoverallprevalenceofHAD.Amorecompleteunderstand-
microglia can be activated by HIV infection itself, by ing of the pathogenesis of HAD wil help identify therapeutic
interaction with viral proteins, or by immune stimulation targets for its prevention and treatment.
due to concurrent infection or other factors7. It is possible
that direct effects of viral proteins on neurons may also HIV entry into the brain and initiation of HAD
contribute to neurodegeneration, although neurons HIV enters the CNS early in the course of infection, and the
themselves are not infected by HIV-1. Here we review the virus resides primarily in microglia and macrophages.
extracellular and intracellular signalling pathways leading However, infection of these cells may not be sufficient to ini-
to macrophage or microglial activation, as well as those tiate neurodegeneration12. It has been proposed that factors
induced in neurons and astrocytes. These pathways are of associated with advanced HIV infection in the periphery
potential therapeutic importance as targets for the (non-CNS) are important triggers for events leading to
prevention or treatment of HAD. dementia. One such factor could be the increased number
TheprevalenceofHADwasestimatedintheearly1990sto of circulating monocytes that express CD16 and CD69.
be as high as 20–30% of those patients with advanced HIV
disease and low CD4 counts8. Many experts believe that HAD
is now the most common cause of dementia worldwide
Aedes aegypti
These activated cells adhere to the normal endothelium of
the brain microvasculature, transmigrate, and then trigger
a number of deleterious processes12.
among people aged 40 or less, and it is a significant indepen- The blood–brain barrier (BBB) is crucial in HIV infec-
dent risk factor for death due to AIDS9. With the advent of tion of the CNS12,14. Microglial and astrocytic chemokines
HAART, the incidence of HAD decreased to as low as 10.5%
(ref. 10), but in recent years its incidence as an AIDS-defining
il ness has actually increased3. The proportion of new cases of
Vetor urbano
(cell migration (chemotaxis)-inducing cytokines), such as
monocyte chemoattractant protein (MCP)-1, seem to
regulate migration of peripheral blood mononuclear cells
HAD demonstrating a CD4 count greater than 200 !l"1 is through the BBB14. Histological studies in specimens from
also increasing10. Moreover, a less fulminant form of HIV-1-infected humans and simian immunodeficiency
neurological dysfunction, termed minor cognitive/motor
disorder (MCMD), may be more prevalent than frank
dementia in the HAART era, and remains a significant
virus (SIV)-infected rhesus macaques show that lympho-
cytes and monocytes migrate into the brain15,16. However,
the pathophysiological relevance of CNS-invading
Vetor silvestre
988 NATURE | VOL 410 | 19 APRIL 2001 | www.nature.com
Pathways to neuronal injury and Febre amarela
apoptosis in HIV-associated dementia
Marcus Kaul*, Gwenn A. Garden† & Stuart A. Lipton*
*Center for Neuroscience and Aging Research, The Burnham Institute, 10901 North Torrey Pines Road, La Jol a, California 92037, USA
(e-mail: mkaul@burnham.org and slipton@burnham.org)
†Department of Neurology, University of Washington, Seattle, Washington 98195, USA (email: gagarden@u.washington.edu)
Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming occurrence worldwide. The
mechanism remains poorly understood, but discovery in brain of HIV-1-binding sites (chemokine receptors)
provides new insights. HIV-1 infects macrophages and microglia, but not neurons, although neurons are
injured and die by apoptosis. The predominant pathway to neuronal injury is indirect through release of
macrophage, microglial and astrocyte toxins, although direct injury by viral proteins might also contribute.
These toxins overstimulate neurons, resulting in the formation of free radicals and excitotoxicity, similar to
other neurodegenerative diseases. Recent advances in understanding the signalling pathways mediating
these events offer hope for therapeutic intervention.
T
he syndrome of cognitive and motor independent risk factor for AIDS mortality9. These findings
dysfunction observed after infection with support the hypothesis that HAART does not provide
human HIV-1 has been designated HIV- complete protection from the development of HAD.
associated dementia (HAD). Although highly Unfortunately, HIV protease inhibitors and several of the
active antiretroviral therapy (HAART) has nucleoside analogues penetrate poorly into the CNS11, allow-
resulted in a decrease in the incidence of HAD1,2, it does ingearlyCNSinfectiontoevolveindependentlyovertimeina
not seem to provide complete protection from or reversal protected brain reservoir. Thus, despite the finding that
of HAD3,4, and the prevalence of the dementia may improved systemic control of viral replication is associated
eventually increase as people live longer with AIDS5,6. with a decrease in the incidence of HAD, whether this effect
Currently there is no specific treatment for HAD, mainly wil be long lasting is open to question4,12. In fact, distinct
because of an incomplete understanding of how HIV antiviral drug-resistance patterns in the plasma and
infection causes neuronal injury and apoptosis. The cerebrospinal fluid (CSF) compartments have recently been
principal pathway for HIV entry into the central nervous reported13. It is possible that the proportion of HIV-infected
system (CNS) is through infected monocytes. The individuals who develop disability secondary to HAD wil
predominant pathogenesis of HAD is believed to involve increase as improvements in control of peripheral viral
activation of monocytic cells (macrophages and replication and the treatment of opportunistic infections
microglia) and their subsequent release of toxins that lead continue to extend life expectancy, resulting in an increase in
to neuronal and astrocytic dysfunction. Macrophages and theoverallprevalenceofHAD.Amorecompleteunderstand-
microglia can be activated by HIV infection itself, by ing of the pathogenesis of HAD wil help identify therapeutic
interaction with viral proteins, or by immune stimulation targets for its prevention and treatment.
due to concurrent infection or other factors7. It is possible
that direct effects of viral proteins on neurons may also HIV entry into the brain and initiation of HAD
contribute to neurodegeneration, although neurons HIV enters the CNS early in the course of infection, and the
themselves are not infected by HIV-1. Here we review the virus resides primarily in microglia and macrophages.
extracellular and intracellular signalling pathways leading However, infection of these cells may not be sufficient to ini-
to macrophage or microglial activation, as well as those tiate neurodegeneration12. It has been proposed that factors
induced in neurons and astrocytes. These pathways are of associated with advanced HIV infection in the periphery
potential therapeutic importance as targets for the (non-CNS) are important triggers for events leading to
prevention or treatment of HAD. dementia. One such factor could be the increased number
TheprevalenceofHADwasestimatedintheearly1990sto of circulating monocytes that express CD16 and CD69.
be as high as 20–30% of those patients with advanced HIV These activated cells adhere to the normal endothelium of
disease and low CD4 counts8. Many experts believe that HAD the brain microvasculature, transmigrate, and then trigger
is now the most common cause of dementia worldwide a number of deleterious processes12.
among people aged 40 or less, and it is a significant indepen- The blood–brain barrier (BBB) is crucial in HIV infec-
dent risk factor for death due to AIDS9. With the advent of tion of the CNS12,14. Microglial and astrocytic chemokines
HAART, the incidence of HAD decreased to as low as 10.5% (cell migration (chemotaxis)-inducing cytokines), such as
(ref. 10), but in recent years its incidence as an AIDS-defining monocyte chemoattractant protein (MCP)-1, seem to
il ness has actually increased3. The proportion of new cases of regulate migration of peripheral blood mononuclear cells
HAD demonstrating a CD4 count greater than 200 !l"1 is through the BBB14. Histological studies in specimens from
also increasing10. Moreover, a less fulminant form of
neurological dysfunction, termed minor cognitive/motor
Figura 6 - O “iceberg” da febre amarela. Distribuição das formas clínicas.
HIV-1-infected humans and simian immunodeficiency
virus (SIV)-infected rhesus macaques show that lympho-
disorder (MCMD), may be more prevalent than frank cytes and monocytes migrate into the brain15,16. However,
dementia in the HAART era, and remains a significant
988
the pathophysiological relevance of CNS-invading
NATURE | VOL 410 | 19 APRIL 2001 | www.nature.com
Revista da Sociedade Brasileira de Medicina Tropical 36:275-293, mar-abr, 2003
s demais indivíduos desenvolvem formas clínicas quadros clássicos de febre amarela, graves e
Febre amarela
exuberantes e outros exibem quadro graves. Aí elevado percentual de fatalidade (Tabela 2).
Grave 3-5 além dos anteriores, icterícia, agricultor, pescador, caçador, lenhador,
hematêmese ou oligúria turista e outros suscetíveis com
imunidade cruzada para Flavivirus
Maligna ≥6 todos os sintomas clássicos Mesmo grupo de pessoas sem imunidade
ormas leve e moderada: a sintomatologia observada o paciente se recupera inteiramente sem seqü
ormas leve e moderada revela-se incaracterística e Apresenta-se de forma silenciosa de difícil diagn
unde-se com a encontrada em outras doenças mesmo durante as epidemias de febre ama
ciosas comuns em áreas endêmicas entre as quais podendo ser confundida com mal estar passa
ais importantes são a malária, as hepatites virais, a resfriado e enxaqueca. Apenas as provas espec
tifóide e a mononucleose infecciosa. definem o diagnóstico.
m geral, os sintomas na forma leve restringem-se Na forma moderada, o quadro clínico mos
rícula ou febre moderada de início súbito que pode arrastado e conspícuo. O paciente refere início
ão vir acompanhada de cefaléia discreta, astenia com febre e cefaléia. Além desses sintomas ele
ndisposição passageira e tontura. Esse quadro apresentar náuseas com ou sem vômitos, mialg
Revista
ui por algumas horas até dois dias, da Sociedade
findos os quaisBrasileira
Figura 7- Febre amarela. Paciente em coma com
quadro maligno. Notar hemorragia.
de Medicina
artralgias Tropical
que não 36:275-293,
incomodam mar-abr, 2003
o paciente nem dific
Febre amarela
Áreas de risco
Diagnóstico Laboratorial
• Isolamento viral (cultura celular e camundongos)
Prevenção e Controle
Cepa 17D
Pathways to neuronal injury and DENV, ZIKV, CHIKV
apoptosis in HIV-associated dementia
Vetores: Ae. aegypti e Ae. albopictus
Dengue
Marcus Kaul*, Gwenn A. Garden† & Stuart A. Lipton*
*Center for Neuroscience and Aging Research, The Burnham Institute, 10901 North Torrey Pines Road, La Jol a, California 92037, USA
(e-mail: mkaul@burnham.org and slipton@burnham.org)
†Department of Neurology, University of Washington, Seattle, Washington 98195, USA (email: gagarden@u.washington.edu)
Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming occurrence worldwide. The
mechanism remains poorly understood, but discovery in brain of HIV-1-binding sites (chemokine receptors)
provides new insights. HIV-1 infects macrophages and microglia, but not neurons, although neurons are
Família: Flaviviridae
injured and die by apoptosis. The predominant pathway to neuronal injury is indirect through release of
macrophage, microglial and astrocyte toxins, although direct injury by viral proteins might also contribute.
These toxins overstimulate neurons, resulting in the formation of free radicals and excitotoxicity, similar to
other neurodegenerative diseases. Recent advances in understanding the signalling pathways mediating
Gênero Flavivirus
these events offer hope for therapeutic intervention.
T Sorotipos 1, 2, 3 e 4 Zika
he syndrome of cognitive and motor independent risk factor for AIDS mortality9. These findings
dysfunction observed after infection with support the hypothesis that HAART does not provide
human HIV-1 has been designated HIV- complete protection from the development of HAD.
associated dementia (HAD). Although highly Unfortunately, HIV protease inhibitors and several of the
Família: Flaviviridae
of HAD3,4, and the prevalence of the dementia may improved systemic control of viral replication is associated
40-65 nm
eventually increase as people live longer with AIDS5,6.
Currently there is no specific treatment for HAD, mainly
with a decrease in the incidence of HAD, whether this effect
wil be long lasting is open to question4,12. In fact, distinct
Chikungunya
because of an incomplete understanding of how HIV antiviral drug-resistance patterns in the plasma and
Gênero Flavivirus
infection causes neuronal injury and apoptosis. The cerebrospinal fluid (CSF) compartments have recently been
Envelopado
principal pathway for HIV entry into the central nervous
system (CNS) is through infected monocytes. The
predominant pathogenesis of HAD is believed to involve
reported13. It is possible that the proportion of HIV-infected
individuals who develop disability secondary to HAD wil
increase as improvements in control of peripheral viral
RNAfs (+)
activation of monocytic cells (macrophages and replication and the treatment of opportunistic infections
microglia) and their subsequent release of toxins that lead continue to extend life expectancy, resulting in an increase in
to neuronal and astrocytic dysfunction. Macrophages and
microglia can be activated by HIV infection itself, by
theoverallprevalenceofHAD.Amorecompleteunderstand-
ing of the pathogenesis of HAD wil help identify therapeutic Família: Togaviridae
40-65 nm
interaction with viral proteins, or by immune stimulation targets for its prevention and treatment.
due to concurrent infection or other factors7. It is possible
that direct effects of viral proteins on neurons may also
contribute to neurodegeneration, although neurons
HIV entry into the brain and initiation of HAD
HIV enters the CNS early in the course of infection, and the Gênero Alphavirus
Envelopado
themselves are not infected by HIV-1. Here we review the virus resides primarily in microglia and macrophages.
extracellular and intracellular signalling pathways leading However, infection of these cells may not be sufficient to ini-
to macrophage or microglial activation, as well as those
induced in neurons and astrocytes. These pathways are of
tiate neurodegeneration12. It has been proposed that factors
associated with advanced HIV infection in the periphery RNAfs (+)
Isolado em 1947
potential therapeutic importance as targets for the (non-CNS) are important triggers for events leading to
prevention or treatment of HAD. dementia. One such factor could be the increased number
TheprevalenceofHADwasestimatedintheearly1990sto
be as high as 20–30% of those patients with advanced HIV
of circulating monocytes that express CD16 and CD69.
These activated cells adhere to the normal endothelium of 65-70 nm
disease and low CD4 counts8. Many experts believe that HAD
(Uganda)
the brain microvasculature, transmigrate, and then trigger
is now the most common cause of dementia worldwide a number of deleterious processes12.
among people aged 40 or less, and it is a significant indepen-
dent risk factor for death due to AIDS9. With the advent of
The blood–brain barrier (BBB) is crucial in HIV infec-
tion of the CNS12,14. Microglial and astrocytic chemokines Envelopado
HAART, the incidence of HAD decreased to as low as 10.5% (cell migration (chemotaxis)-inducing cytokines), such as
(ref. 10), but in recent years its incidence as an AIDS-defining monocyte chemoattractant protein (MCP)-1, seem to
il ness has actually increased3. The proportion of new cases of
HAD demonstrating a CD4 count greater than 200 !l"1 is
also increasing10. Moreover, a less fulminant form of
regulate migration of peripheral blood mononuclear cells
through the BBB14. Histological studies in specimens from
HIV-1-infected humans and simian immunodeficiency
Isolado em 1950
neurological dysfunction, termed minor cognitive/motor
disorder (MCMD), may be more prevalent than frank
dementia in the HAART era, and remains a significant
virus (SIV)-infected rhesus macaques show that lympho-
cytes and monocytes migrate into the brain15,16. However,
the pathophysiological relevance of CNS-invading
(Tanzânia)
988 NATURE | VOL 410 | 19 APRIL 2001 | www.nature.com
Pathways to neuronal injury and DENV, ZIKV, CHIKV
apoptosis in HIV-associated dementia
Genoma dos Flavivírus
Marcus Kaul*, Gwenn A. Garden† & Stuart A. Lipton*
*Center for Neuroscience and Aging Research, The Burnham Institute, 10901 North Torrey Pines Road, La Jol a, California 92037, USA
(e-mail: mkaul@burnham.org and slipton@burnham.org)
†Department of Neurology, University of Washington, Seattle, Washington 98195, USA (email: gagarden@u.washington.edu)
Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming occurrence worldwide. The
mechanism remains poorly understood, but discovery in brain of HIV-1-binding sites (chemokine receptors)
provides new insights. HIV-1 infects macrophages and microglia, but not neurons, although neurons are
injured and die by apoptosis. The predominant pathway to neuronal injury is indirect through release of
macrophage, microglial and astrocyte toxins, although direct injury by viral proteins might also contribute.
These toxins overstimulate neurons, resulting in the formation of free radicals and excitotoxicity, similar to
other neurodegenerative diseases. Recent advances in understanding the signalling pathways mediating
these events offer hope for therapeutic intervention.
T
he syndrome of cognitive and motor independent risk factor for AIDS mortality9. These findings
dysfunction observed after infection with support the hypothesis that HAART does not provide
human HIV-1 has been designated HIV- complete protection from the development of HAD.
associated dementia (HAD). Although highly Unfortunately, HIV protease inhibitors and several of the
active antiretroviral therapy (HAART) has nucleoside analogues penetrate poorly into the CNS11, allow-
resulted in a decrease in the incidence of HAD1,2, it does
not seem to provide complete protection from or reversal
of HAD3,4, and the prevalence of the dementia may
Estruturais
ingearlyCNSinfectiontoevolveindependentlyovertimeina
protected brain reservoir. Thus, despite the finding that
improved systemic control of viral replication is associated
eventually increase as people live longer with AIDS5,6. with a decrease in the incidence of HAD, whether this effect
Currently there is no specific treatment for HAD, mainly
because of an incomplete understanding of how HIV
wil be long lasting is open to question4,12. In fact, distinct
antiviral drug-resistance patterns in the plasma and
Não estruturais
infection causes neuronal injury and apoptosis. The cerebrospinal fluid (CSF) compartments have recently been
principal pathway for HIV entry into the central nervous reported13. It is possible that the proportion of HIV-infected
system (CNS) is through infected monocytes. The individuals who develop disability secondary to HAD wil
Ciclo de replicação
Boletim Epidemiologia: DENV, ZIKV, CHIKV
Epidemiológico Volume 47
N° 18 - 2016
Dengue
Monitoramento dos casos de que as regiões Centro-Oeste e Sudeste apresentam
dengue, febre de chikungunya e as maiores taxas de incidências, mantendo-se a
Maisvírus
febre pelo deZika
390atémilhões
a Semanade novas infecções por ano
tendência de 2015: 613,1 casos/100 mil hab. e
Epidemiológica 13, 2016 540,9 casos/100 mil hab., respectivamente. Entre
as Unidades da Federação, destacam-se Minas
Dengue Brasil (2016) - 802.429 casos prováveis Gerais (1.332,5 casos/100 mil hab.), Rio Grande do
Em 2016, foram registrados 802.429 casos Norte (857 casos/100 mil hab.) e Mato Grosso do
prováveis de dengue no país até a Semana Sul (825,9 casos/100 mil hab.) (Tabela 1).
Entre os municípios com as maiores taxas
Sudeste (57,8%): 463.807 casos
Epidemiológica (SE) 13 (3/1/2016 a 2/4/2016)
(Figura 1). Nesse período, a região Sudeste de incidências no mês de fevereiro por estrato
registrou o maior número de casos prováveis populacional, em relação ao número de habitantes
Nordeste (19,7%): 158.235 casos
(463.807 casos; 57,8%) em relação ao total do (menos de 100 mil habitantes, de 100 a 499 mil, de
500 a 999 mil e acima de 1 milhão de habitantes),
país, seguida das regiões Nordeste (158.235 casos;
19,7%), Centro-Oeste (94.672 casos; 11,8%), Sul destacam-se Guamaré/RN, com 12.929,7 casos/100
Centro-Oeste (11,8%): 94.672 casos
(57.282 casos; 7,1%) e Norte (28.433 casos; 3,5%) mil hab. (população <100 mil hab.); Itabuna/BA,
(Tabela 1). Foram descartados 161.273 casos com 2.751,7 casos/100 mil hab. (população de 100
suspeitos de dengue no período. mil a 499 mil hab.); Contagem/MG, com 1.394,8
Sul (7,1%): 57.282 casos
A análise da taxa de incidência de casos casos/100 mil hab. (população de 500 mil a 999 mil
prováveis de dengue (número de casos/100 mil hab.); e Belo Horizonte/MG, com 1.547,4 casos/100
hab.), segundo regiões geográficas, demonstra Norte (3,5%): 28.433 casos
mil hab. (população >1 milhão de hab.) (Tabela 2).
Boletim Epidemiologia: DENV
Epidemiológico Volume 47
N° 18 - 2016
Boletim Epidemiológ
Secretaria de Vigilância em Saúde − Ministério da Saúde − Br
Secretaria de Vigilância em Saúde − Ministério da Saúde
ISSN 2358-9450
Tabela 1 – Comparativo de casos prováveis de dengue entre 2015a e 2016b, até a Semana Epidemiológica 13, por região e
Unidade da Federação
Monitoramento dos casos de que as regiões Centro-Oeste e Sudeste apresentam
dengue, febre de chikungunya e as maiores taxas de incidências, mantendo-se a
febre pelodavírus
Região/Unidade Zika até a Semana
Federação
tendência de 2015: 613,1 casos/100
Casos (n) Incidênciamil
(/100hab. e
mil hab.)
Exantemas
Pathways to neuronal injury and Dengue
apoptosis in HIV-associated dementia
Marcus Kaul*, Gwenn A. Garden† & Stuart A. Lipton*
*Center for Neuroscience and Aging Research, The Burnham Institute, 10901 North Torrey Pines Road, La Jol a, California 92037, USA
(e-mail: mkaul@burnham.org and slipton@burnham.org)
†Department of Neurology, University of Washington, Seattle, Washington 98195, USA (email: gagarden@u.washington.edu)
Quadro clínico
Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming occurrence worldwide. The
mechanism remains poorly understood, but discovery in brain of HIV-1-binding sites (chemokine receptors)
provides new insights. HIV-1 infects macrophages and microglia, but not neurons, although neurons are
injured and die by apoptosis. The predominant pathway to neuronal injury is indirect through release of
T
he syndrome of cognitive and motor independent risk factor for AIDS mortality9. These findings
dysfunction observed after infection with support the hypothesis that HAART does not provide
human HIV-1 has been designated HIV- complete protection from the development of HAD.
associated dementia (HAD). Although highly Unfortunately, HIV protease inhibitors and several of the
Epidemiológico Volume 47
N° 18 - 2016
120.000
100.000
80.000
Número de casos
60.000
Sem registro
40.000
Casos confirmados
20.000 Casos notificados
0
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53
Figura 3 – Casos prováveis e confirmados de febre de chikungunya por município de notificação, até a Semana
Epidemiológica 13, Brasil, 2016
Pathways to neuronal injury and Chikungunya
apoptosis in HIV-associated dementia
Marcus Kaul*, Gwenn A. Garden† & Stuart A. Lipton*
*Center for Neuroscience and Aging Research, The Burnham Institute, 10901 North Torrey Pines Road, La Jol a, California 92037, USA
(e-mail: mkaul@burnham.org and slipton@burnham.org)
†Department of Neurology, University of Washington, Seattle, Washington 98195, USA (email: gagarden@u.washington.edu)
Quadro clínico
Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming occurrence worldwide. The
mechanism remains poorly understood, but discovery in brain of HIV-1-binding sites (chemokine receptors)
provides new insights. HIV-1 infects macrophages and microglia, but not neurons, although neurons are
injured and die by apoptosis. The predominant pathway to neuronal injury is indirect through release of
macrophage, microglial and astrocyte toxins, although direct injury by viral proteins might also contribute.
These toxins overstimulate neurons, resulting in the formation of free radicals and excitotoxicity, similar to
quadros de febre associados à dor articular intensa e
other neurodegenerative diseases. Recent advances in understanding the signalling pathways mediating
these events offer hope for therapeutic intervention.
T
he syndrome of cognitive and motor debilitante, cefaléia e mialgia
dysfunction observed after infection with
independent risk factor for AIDS mortality9. These findings
support the hypothesis that HAART does not provide
human HIV-1 has been designated HIV- complete protection from the development of HAD.
associated dementia (HAD). Although highly Unfortunately, HIV protease inhibitors and several of the
active antiretroviral therapy (HAART) has nucleoside analogues penetrate poorly into the CNS11, allow-
resulted in a decrease in the incidence of HAD1,2, it does ingearlyCNSinfectiontoevolveindependentlyovertimeina
not seem to provide complete protection from or reversal protected brain reservoir. Thus, despite the finding that
of HAD3,4, and the prevalence of the dementia may improved systemic control of viral replication is associated
eventually increase as people live longer with AIDS5,6. with a decrease in the incidence of HAD, whether this effect
Epidemiológico Volume 47
N° 18 - 2016
Epidemiológico
Fonte: Sinan-NET (atualizado em 07/04/2016).
Figura 4 – Taxa de incidência (/100 mil hab.) de febre pelo vírus Zika por município de notificação, até a Semana
Volume 47
N° 18 - 2016
Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming occurrence worldwide. The
mechanism remains poorly understood, but discovery in brain of HIV-1-binding sites (chemokine receptors)
provides new insights. HIV-1 infects macrophages and microglia, but not neurons, although neurons are
injured and die by apoptosis. The predominant pathway to neuronal injury is indirect through release of
macrophage, microglial and astrocyte toxins, although direct injury by viral proteins might also contribute.
These toxins overstimulate neurons, resulting in the formation of free radicals and excitotoxicity, similar to
other neurodegenerative diseases. Recent advances in understanding the signalling pathways mediating
these events offer hope for therapeutic intervention.
T
he syndrome of cognitive and motor independent risk factor for AIDS mortality9. These findings
dysfunction observed after infection with support the hypothesis that HAART does not provide
human HIV-1 has been designated HIV- complete protection from the development of HAD.
associated dementia (HAD). Although highly Unfortunately, HIV protease inhibitors and several of the
active antiretroviral therapy (HAART) has nucleoside analogues penetrate poorly into the CNS11, allow-
resulted in a decrease in the incidence of HAD1,2, it does ingearlyCNSinfectiontoevolveindependentlyovertimeina
not seem to provide complete protection from or reversal protected brain reservoir. Thus, despite the finding that
of HAD3,4, and the prevalence of the dementia may improved systemic control of viral replication is associated
eventually increase as people live longer with AIDS5,6. with a decrease in the incidence of HAD, whether this effect
Currently there is no specific treatment for HAD, mainly wil be long lasting is open to question4,12. In fact, distinct
because of an incomplete understanding of how HIV antiviral drug-resistance patterns in the plasma and
infection causes neuronal injury and apoptosis. The cerebrospinal fluid (CSF) compartments have recently been
principal pathway for HIV entry into the central nervous reported13. It is possible that the proportion of HIV-infected
system (CNS) is through infected monocytes. The individuals who develop disability secondary to HAD wil
predominant pathogenesis of HAD is believed to involve increase as improvements in control of peripheral viral
activation of monocytic cells (macrophages and replication and the treatment of opportunistic infections
microglia) and their subsequent release of toxins that lead continue to extend life expectancy, resulting in an increase in
to neuronal and astrocytic dysfunction. Macrophages and theoverallprevalenceofHAD.Amorecompleteunderstand-
microglia can be activated by HIV infection itself, by ing of the pathogenesis of HAD wil help identify therapeutic
interaction with viral proteins, or by immune stimulation targets for its prevention and treatment.
due to concurrent infection or other factors7. It is possible
that direct effects of viral proteins on neurons may also HIV entry into the brain and initiation of HAD
contribute to neurodegeneration, although neurons HIV enters the CNS early in the course of infection, and the
themselves are not infected by HIV-1. Here we review the virus resides primarily in microglia and macrophages.
extracellular and intracellular signalling pathways leading However, infection of these cells may not be sufficient to ini-
to macrophage or microglial activation, as well as those tiate neurodegeneration12. It has been proposed that factors
induced in neurons and astrocytes. These pathways are of associated with advanced HIV infection in the periphery
potential therapeutic importance as targets for the (non-CNS) are important triggers for events leading to
prevention or treatment of HAD. dementia. One such factor could be the increased number
TheprevalenceofHADwasestimatedintheearly1990sto of circulating monocytes that express CD16 and CD69.
be as high as 20–30% of those patients with advanced HIV These activated cells adhere to the normal endothelium of
disease and low CD4 counts8. Many experts believe that HAD the brain microvasculature, transmigrate, and then trigger
is now the most common cause of dementia worldwide a number of deleterious processes12.
among people aged 40 or less, and it is a significant indepen- The blood–brain barrier (BBB) is crucial in HIV infec-
dent risk factor for death due to AIDS9. With the advent of tion of the CNS12,14. Microglial and astrocytic chemokines
HAART, the incidence of HAD decreased to as low as 10.5% (cell migration (chemotaxis)-inducing cytokines), such as
(ref. 10), but in recent years its incidence as an AIDS-defining monocyte chemoattractant protein (MCP)-1, seem to
il ness has actually increased3. The proportion of new cases of regulate migration of peripheral blood mononuclear cells
HAD demonstrating a CD4 count greater than 200 !l"1 is through the BBB14. Histological studies in specimens from
also increasing10. Moreover, a less fulminant form of HIV-1-infected humans and simian immunodeficiency
neurological dysfunction, termed minor cognitive/motor virus (SIV)-infected rhesus macaques show that lympho-
disorder (MCMD), may be more prevalent than frank cytes and monocytes migrate into the brain15,16. However,
dementia in the HAART era, and remains a significant the pathophysiological relevance of CNS-invading
988 NATURE | VOL 410 | 19 APRIL 2001 | www.nature.com
lineages of the virus,6 and the latter strains and Vapalahti contributed equally to this
Brief Report
ic and the Americas.7 As in the transmission article.
theZika main Virus transmission
Infection with cycle Prolonged of ZIKV Maternal occurs This article was published on March 30,
humans. Viremia and Fetal Brain Abnormalities 2016, at NEJM.org.
ZIKV outbreak is the apparentT increased h e n e w e ng lrisk
R.W. Driggers, C.-Y. Ho, E.M. Korhonen, S. Kuivanen, A.J. Jääskeläinen, T. Smura,
A. Rosenberg, D.A. Hill, R.L. DeBiasi, G. Vezina, J. Timofeev, F.J. Rodriguez,
a n d j o u r na l o f m e dic i n e
DOI: 10.1056/NEJMoa1601824
sion of the virus as and
A. du Plessis, well as the marked in- Copyright © 2016 Massachusetts Medical Society.
L. Levanov, J. Razak, P. Iyengar, A. Hennenfent, R. Kennedy, R. Lanciotti,
O. Vapalahti
trophy, or
centile between 16brain
and 20 weekscalcifications. 11
of gestation. ZIKV RNA was identifiedBecause
nal serum at 16 and 21 weeks of gestation. At 19 and 20 weeks of gestation,
in mater- of
ionsubstantial
and
Gestational
microcephaly
Week
brain abnormalities
resonance imaging (MRI) without the 12 and
presence13 other
14
of microcephaly neurologic
were detected on ultrasonography and magnetic
or 15
intracranial16 17 18 19 20
Termination of Pregnancy
tionthinning,
hashighdeclared
ZIKV RNA loads,the ZIKV
and viral epidemic
particles were detected, and ZIKV a waspublic
calcifications. On postmortem analysis of the fetal brain, diffuse cerebral cortical
subsequently isolated.
ncern.13
Z
investigations into the viral pathogenesis,
ika virus (ZIKV), a mosquito-borne flavivirus and member of the The authors’ full names, academic de-
Flaviviridae family, was originally isolated from a sentinel primate in Ugan- grees, and affiliations are listed in the Ap-
virallar rash
cofactors, and sensitivity andSerum specificity
pendix. Address reprint requests to Dr.
da in 1947. ZIKV was associated with mild febrile disease and maculopapu-
1
Driggers at rdrigge1@jhmi.edu, to Dr. du
in tropical Africa and some areas of Southeast Asia. Since 2007, ZIKV has
sampledPlessis at adupless@childrensnational
.5
10
15
20
25
.5
5
.2
.1
.1
.2
.2
.1
.1
prospective study showed fetal ultrasonographic abnormalities in 12 of 42 women
n.
ec
b
n.
n.
n.
n.
ec
ec
b
ov
ec
ec
Fe
Fe
Ja
Ja
Ja
Ja
(29%) with ZIKV infection during pregnancy; 7 of the 42 fetuses (17%) that were
D
D
N
T
Ana M. Bispo de Filippis, Ph.D., and Karin M.D.
women.
HAD demonstrating a CD4 Fetal
n engl j med
il ness has actually increased3. The proportion of new cases of regulate migration of peripheral blood mononuclear cells
count greater than 200 !l"1abnormalities
nejm.org
is through the BBB14. Histological studies in specimens from were detected by Doppler ultrasonography in 12 of the 42
1
10
ZIKV-positive women (29%) and in none of the 16 ZIKV-negative women. Adverse find-
also increasing . Moreover, a less fulminant form of HIV-1-infected humans and simian immunodeficiency
neurological dysfunction, termed minor cognitive/motor virus (SIV)-infected rhesus macaques show that lympho-
ings The New England Journal of Medicine
included
disorder (MCMD), may be more prevalent than frankfetal cytes and monocytdeaths
es migrate into the brain15,16. Howeverat , 36 and 38 weeks of gestation (2 fetuses), in utero growth
dementia in the HAART era, and remains a significant the pathophysiological relevance of CNS-invading
restriction with or on
Z MACHADO without microcephaly (5 fetuses), ventricular use
calcifications or other
988 | | March
| 7, 2016. For personal only. No other uses without permission.
NATURE VOL 410 19 APRIL 2001 www.nature.com
central nervous system (CNS) lesions (7 fetuses), and abnormal amniotic fluid volume
ed from September 2015 through February 2016; of
PatZika
positive hways tofor neuroVirus nalZIKV injury and Infection in blood, urine, or both. Women
in Pregnant The timing
at knielsen@mednet.ucla.edu.
om apopt oto sis inRio HI38 V-associweeks atde ed dementJaneiro ia of gestation. This article was published on March 4,
5in Predominant
— Preliminary Report clinical 2016, at NEJM.org.
ndingPatrícia macular
Marcus Kaul*, Gwenn A. Garden† & Stuart A. Lipton*
or maculopapular rash, arthralgias,
Brasil, M.D., Jose P. Pereira, Jr., M.D., Claudia Raja Gabaglia, M.D.,
*Center for Neuroscience and Aging Research, The Burnham Institute, 10901 North Torrey Pines Road, La Jol a, California 92037, USA DOI: 10.1056/NEJMoa1602412
ache; 28%Luana(e-mail: mkaul@burnham.org and slipton@burnham.org)
hadDamasceno, fever M.S.,
†Department of Neurology, University of Washington, Seattle, Washington 98195, USA (email: gagarden@u.washington.edu) (short-term
Mayumi Wakimoto, andPh.D.,low-grade). Copyright © 2016 Massachusetts Medical Society.
Rita M. Ribeiro Nogueira, M.D., Patrícia Carvalho de Sequeira, Ph.D.,
Human immunodeficiency virus-1 (HIV-1) can induce dementia with alE F
V were y understmore
mechanism remains poorlAndré in brain of HIV-1-bindinlikely
ood, but discovery Machado
arming occurrence worldwide. The
g sites (chemokine receptSiqueira,
ors) thanM.D.,those
Liege M.who
Abreuwere negative
de Carvalho, M.D., for
provides new insights. HIV-1 infects macrophages and mi c rogl ia, but not neurons, al t hough
Denise Cotrim da Cunha, M.D., Guilherme A. Calvet, M.D., neurons are
ashElizabeth
(44% vs. 12%,
injured and die by apoptosis. The predominant pathway to neuronal injury is indirect through release of
macrophage, microglial and astrocytS.e toxins, altNeves,
hough direct injury by viral proteinsM.D.,
P = 0.02), conjunctival involvement
might also contribute. Maria E. Moreira, M.D., Ana E. Rodrigues Baião, M.D.,
These toxins overstimulate neurons, resulting in the formation of free radicals and excitotoxicity, similar to
mphadenopathy
other neurodegenerative diseases. Recent advancesPaulo in understanding the signalR.
these events offer hope for therapeutic interventStephanie
ion.
(40%
ling pathwaysNassar
mediating devs. 7%,
Carvalho, P
M.D.,= 0.02).
Carla Fetal
Janzen,
G. Valderramos, M.D., James D. Cherry, M.D.,
M.D., ultraso-
T
Ana M. Bispo de Filippis, Ph.D., and Karin M.D.
women.
HAD demonstrating a CD4 Fetal
n engl j med
il ness has actually increased3. The proportion of new cases of regulate migration of peripheral blood mononuclear cells
count greater than 200 !l"1abnormalities
nejm.org
is through the BBB14. Histological studies in specimens from were detected by Doppler ultrasonography in 12 of the 42
1
10
ZIKV-positive women (29%) and in none of the 16 ZIKV-negative women. Adverse find-
also increasing . Moreover, a less fulminant form of HIV-1-infected humans and simian immunodeficiency
neurological dysfunction, termed minor cognitive/motor virus (SIV)-infected rhesus macaques show that lympho-
ings The New England Journal of Medicine
included
disorder (MCMD), may be more prevalent than frankfetal cytes and monocytdeaths
es migrate into the brain15,16. Howeverat , 36 and 38 weeks of gestation (2 fetuses), in utero growth
dementia in the HAART era, and remains a significant the pathophysiological relevance of CNS-invading
restriction with or on
Z MACHADO without microcephaly (5 fetuses), ventricular use
calcifications or other
988 | | March
| 7, 2016. For personal only. No other uses without permission.
NATURE VOL 410 19 APRIL 2001 www.nature.com
central nervous system (CNS) lesions (7 fetuses), and abnormal amniotic fluid volume
ated
Pathwaysfor
to neuronalainjursubgroup
y andT h e n e w e ng lof pregnant women. Con- quests to Dr. Honein at the National Cen-
microcephaly
apoptosis in HIV-associated dementia for evidence of congenital ZVD.
a n d j o u r na l o f m e dic i n e ter on Birth Defects and Developmental
Disabilities, Centers for Disease Control
Marcus Kaul*, Gwenn A. Garden† & Stuart A. Lipton*
*Center for Neuroscience and Aging Research, The Burnham Institute, 10901 North Torrey Pines Road, La Jol a, California 92037, USA Original Article and Prevention, 1600 Clifton Rd. NE, At-
(e-mail: mkaul@burnham.org and slipton@burnham.org)
lanta, GA 30333, or at mhonein@cdc.gov.
cases of ZVD reported in Colombia, of which
†Department of Neurology, University of Washington, Seattle, Washington 98195, USA (email: gagarden@u.washington.edu)
Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming occurrence worldwide. The
mechanism remains poorly understood, but discovery in brain of HIV-1-binding sites (chemokine receptors)
Preliminary
other neurodegenerative diseases. Recent advances in understanding the signalling pathways mediating
these events offer hope for therapeutic intervention.
T
Oscar Pacheco, M.D., Mauricio Beltrán, M.S., Christina A. Nelson, M.D., Copyright © 2016 Massachusetts Medical Society.
he syndrome of cognitive and motor independent risk factor for AIDS mortality9. These findings
JennitaAté
Reefhuis,2/4/2016 - 65.726
of HAD3,4, and the prevalence of the dementia may
Ph.D., Maritza González, M.D., Marcelacasos notificados de ZIKV
improved systemic control of viral replication is associated
Mercado, M.S.,
thirdPablo
trimester had given birth,
Duran, and
eventually increase as people live longer with AIDS5,6.
Currently there is no specific treatment for HAD, mainly
Chaparro, M.D., Mancel Martínez
because of an incomplete understanding of how HIV
no Y.infants
M.D., Carol
with a decrease in the incidence of HAD, whether this effect
wil be long lasting is open to question4,12. In fact, distinct
Rao, Sc.D.,
antiviral drug-resistance patterns in the plasma and
ing microcephaly,
María M. Muñoz, M.D.,haveAnn M.been identified. A ma-
infection causes neuronal injury and apoptosis. The cerebrospinal fluid (CSF) compartments have recently been
Powers, Ph.D., Claudia Cuéllar,
principal pathway for HIV entry into the central nervous M.D.,
reported13. It is possible that the proportion of HIV-infected
Rita Helfand, M.D., Claudia Huguett, M.S., Denise J. Jamieson, M.D.,
system (CNS) is through infected monocytes. The individuals who develop disability secondary to HAD wil
ZVD inMargaret
the first
A. Honein, second
Ph.D., trimester
and Martha
activation of monocytic cells (macrophages and
L. Ospina wereM.D.
Martínez,
microglia) and their subsequent release of toxins that lead
to neuronal and astrocytic dysfunction. Macrophages and
still
replication and the treatment of opportunistic infections
continue to extend life expectancy, resulting in an increase in
theoverallprevalenceofHAD.Amorecompleteunderstand-
ymptomatic
BACKGROUND
mothers who were not included in
to macrophage or microglial activation, as well as those
induced in neurons and astrocytes. These pathways are of
tiate neurodegeneration12. It has been proposed that factors
associated with advanced HIV infection in the periphery
Colombia began official surveillance for Zika virus disease (ZVD) in August 2015. From Instituto Nacional de Salud (O.P.,
potential therapeutic importance as targets for the (non-CNS) are important triggers for events leading to
prevention or treatment of HAD. dementia. One such factor could be the increased number M.B., N.T., A.V.P., E.L.C., L.P., A.R., M.G.,
In October 2015, an outbreak of ZVD was declared after laboratory-confirmed dis-
TheprevalenceofHADwasestimatedintheearly1990sto of circulating monocytes that express CD16 and CD69.
be as high as 20–30% of those patients with advanced HIV These activated cells adhere to the normal endothelium of M.M., P.C., M.M.D., C.H., M.L.O.M.) and
ease was identified in nine patients.
disease and low CD4 counts8. Many experts believe that HAD the brain microvasculature, transmigrate, and then trigger Ministerio de Salud y Protección Social
is now the most common cause of dementia worldwide a number of deleterious processes12.
among people aged 40 or less, and it is a significant indepen- The blood–brain barrier (BBB) is crucial in HIV infec- (M.M.M., C.C.) — both in Bogota, Co-
METHODS
dent risk factor for death due to AIDS9. With the advent of tion of the CNS12,14. Microglial and astrocytic chemokines lombia; and the Centers for Disease Con-
HAART, the incidence of HAD decreased to as low as 10.5% (cell migration (chemotaxis)-inducing cytokines), such as
Using the national population-based surveillance system, we assessed patients with
(ref. 10), but in recent years its incidence as an AIDS-defining monocyte chemoattractant protein (MCP)-1, seem to Nenhum caso de microcefalia
trol and Prevention, Atlanta (C.A.N., D.V.,
T
novation.
infectious ZIKV particles from saliva and urine of acute phase patie
t it was notCopyright: tested earlier. ZIKV
he syndrome of cognitive and motor independent risk factor for AIDS mortality9. These findings
© 2016 Bonaldo et al. This is an open
Disclosure
state, Brazil. forms provided by the authors are available
dysfunction observed after infection with support the hypothesis that HAART does not provide
Damasceno
in a4.,previ-
Iasmim
Atkinson
interfere
, Kely
S. de
polymerase
withMello
among people aged 40 or less, and it is a significant indepen- The blood–brain barrier (BBB) is crucial in HIV infec-
that B,virion
. Microglial and astrocytic chemokines
A. B. da
,infectivity.
Hearn
chain
Silva
Nathália
P, Afrough
reaction
, Marcia
The B, etatal.
(RT-PCR)
complete1☯
a Detection
viral of bothofZIKV
genome 2☯
Zik 3‡
healthy 24-year-old woman (Patient 1) rus whoin count ofEmerg
semen.
HAART, the incidence of HAD decreased to as low as 10.5% (cell migration (chemotaxis)-inducing cytokines), such as
3.5×10 Infect
copiesDis per 2016
milliliter,
(in and the
press) (http://dx.doi.
3
uld G.continue
de Castro , to use
Alexandra condoms
L. Gerber , dur-
(ref. 10), but in recent years its incidence as an AIDS-defining monocyte chemoattractant3‡
Luiz G. P. de
protein (MCP)-1, seem to
Almeida , Ricardo
was living in Paris and in whom acute fever, saliva tested positive at a viral count of 2.1×10
il ness has actually increased3. The proportion of new cases of regulate migration of peripheral blood mononuclear cells Lourenço-de- 4‡ 4‡
4
HAD demonstrating a CD4 count greater than 200 !l"13‡
Oliveira , Ana myalgia, Tereza R. Vasconcelos
arthralgia, and pruritic , Patrícia 10.3201/copies
Brasil
rash developed
eid2205 .160107).
is through the BBB14. Histological studies in specimens from
per milliliter. A plasma sample tested nega-
4‡ 2☯
Full-length
2 sequencing
uim Pinto Nunes Neto, Ana Cecı́lia Ribeiro Cruz, and genetic
2,3
Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming occurrence worldwide. The
mechanism remains poorly understood, but discovery in brain of HIV-1-binding sites (chemokine receptors)
provides new insights. HIV-1 infects macrophages and microglia, but not neurons, although neurons are
characterization of Breu Branco virus (Reoviridae,
injured and die by apoptosis. The predominant pathway to neuronal injury is indirect through release of
2 2
r Mansour Moraes Casseb, Helena Baldez Vasconcelos,
macrophage, microglial and astrocyte toxins, although direct injury by viral proteins might also contribute.
These toxins overstimulate neurons, resulting in the formation of free radicals and excitotoxicity, similar to
State, Brazil
activation of monocytic cells (macrophages and replication and the treatment of opportunistic infections